Historical record - last NADAC effective date: 1/17/2018
Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.0845 per ML under NDC 00054319446. Its NADAC has been published 261 times since Nov 28, 2013.
FDA first approved this application on May 3, 1982.
The High Outlier badge above means this manufacturer's average price in the Diphenoxylate Hydrochloride and Atropine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID
Diphenoxylate Hydrochloride and Atropine SulfateStrength
.025; 2.5 mg/5mL; mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054319446
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
1/17/2018
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA087708FDA Approved
5/3/1982
On Market Since
5/3/1982
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID has been published 261 times since Nov 28, 2013, and over the history we have for it it has risen 742.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0845 per ML |
|---|---|
| All-time high | $1.0845 (Jan 16, 2019) |
| All-time low | $0.1265 (Dec 18, 2013) |
| Median price | $0.2183 |
| Average price | $0.3591 |
| Largest weekly change | +387.6% (Jan 17, 2018) |
| Weeks tracked | 261 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+742.2%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diphenoxylate Hydrochloride and Atropine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diphenoxylate Hydrochloride and Atropine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID, manufactured by Hikma Pharmaceuticals USA Inc., is $1.0845 per ML (NDC 00054319446), effective Jan 16, 2019.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID has risen 742.2%. It has been tracked across 261 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?
Since Nov 28, 2013, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID has ranged from a low of $0.1265 (Dec 18, 2013) to a high of $1.0845 (Jan 16, 2019), with a median of $0.2183 per ML.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG/5 ML LIQUID (NDC 00054319446) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.